Covid policy paper 2022 – Lessons learned

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Open

Open Public Consultation on the revision of EU rules on medicines for children and rare diseases

Open

The Issue of Abuses of Divisional Patent Application

Open

Заповнення прогалини: Filling the gap – Ukrainian translation now available.

Filling the gap – how off-patent medicines can improve the equity and quality of cancer care – Ukrainian translation now available.

Open Ukrainian translation

Medicines for Europe Position on IP Action Plan – March 2021

Open

Maintaining the exchange of critical health data – An adequacy decision on the UK data protection regime

Open

Medicine Shortages Webinar: Damian Holly Supply Chain Resilience Overview.

Medicines for Europe Code of Conduct

OPEN

Life Science Industry Coalition Position paper

Medicines For Europe